High-affinity pituitary GHRH receptor-binding sites

Biomarker

1 paper studies it2 findings

  • Animals1

Interventions

1

Sermorelin

downin rats1upin rats1

1 study
  1. Sermorelin decreases high-affinity pituitary GHRH receptor-binding sites in rats (2.4-fold decrease versus 0.5 mg/kg BW; P < 0.05).

    “Treatment with 1.0 mg/kg GHRH decreased the number of high affinity pituitary GHRH-R-binding sites by 2.4-fold compared with that in rats treated with 0.5 mg/kg BW”

    Animalscompared with 0.5 mg/kg BWhuman GHRH-(1-29)NH2pituitary1.0 mg/kg BW daily14 daysmales

    Differential in vivo regulation of the pituitary growth hormone-releasing hormone (GHRH) receptor by GHRH in young and aged rats

    Endocrinology

  2. Sermorelin increases high-affinity pituitary GHRH receptor-binding sites in rats (2-fold).

    “treatment with 0.5 mg/kg GHRH increased the number of high affinity pituitary GHRH-R-binding sites by 2-fold (P < 0.05)”

    Animalshuman GHRH-(1-29)NH2pituitary0.5 mg/kg BW daily14 daysmales

    Differential in vivo regulation of the pituitary growth hormone-releasing hormone (GHRH) receptor by GHRH in young and aged rats

    Endocrinology

More on Sermorelin

Latest